Sanquin Selects Abbott's "Alinity™ s" Solution for Blood and Plasma Screening
"We conducted an evaluation of multiple potential solutions across numerous parameters to quantify the total value of ownership among screening platforms," said
In a testing specialty that can require extensive hands-on time, the innovative automation and flexibility of the Alinity s platform will help Sanquin increase efficiency while maintaining the high levels of accuracy for blood and plasma screening. "Importantly, the high specificity of the assays for donor screening further minimizes the unnecessary disposal of blood and plasma units given voluntarily by our donors,"
"Abbott is excited to expand our partnership with Sanquin, a global leader in blood and plasma screening," said
About Sanquin
Sanquin is responsible for safe and efficient blood supply in
About Alinity
Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostic platforms and simplifying diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results.
The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics, along with Abbott's AlinIQ—a first-of-its-kind, holistic suite of professional services that combines expertise with process analysis and informatics. Alinity is helping labs and hospital systems solve some of their most pressing challenges to deliver better patient care with fewer resources. The availability of the Alinity systems and tests varies by geography. More information is available at abbott.com/alinity.
About Abbott
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 99,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
______________________________
i The Alinity s system for blood and plasma screening is CE marked and available in select markets; this system is not cleared for use in
View original content with multimedia:http://www.prnewswire.com/news-releases/sanquin-selects-abbotts-alinity-s-solution-for-blood-and-plasma-screening-300633937.html
SOURCE Abbott
Sanquin Media: Merlijn van Hasselt, +31 6 53232124, Chantal van den Berg, +31 6 51414969, Abbott Media: Jessica Masuga, +1 (224) 668-0650, Anita de Groot, +31 (0)88 82 22 643, Abbott Financial: Lukas Szot, +1 (224) 667-2299